TAMIKA HARRIS: Open Payments
NPI 1356886949 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,742 in 84 payments from 12 companies in 2025. Trend: 2023 $1,560 · 2024 $1,454 · 2025 $1,742
Food & beverage: $1,631Education: $111
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $336 |
| Vanda Pharmaceuticals Inc. | 11 | $255 |
| Alkermes, Inc. | 9 | $233 |
| Otsuka America Pharmaceutical, Inc. | 10 | $203 |
| Teva Pharmaceuticals USA, Inc. | 7 | $185 |
| E.R. Squibb & Sons, L.L.C. | 6 | $109 |
| Axsome Therapeutics, Inc. | 4 | $107 |
| Neurocrine BioSciences, Inc. | 3 | $90 |
| Lundbeck LLC | 4 | $77 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $66 |
Products named: VRAYLAR, REXULTI, FANAPT, ARISTADA, COBENFY, Auvelity, INGREZZA, AUSTEDO XR.
Industry payments across AL — which companies pay providers there.
